Fig. 5: Immunoreactivities of resected lymph nodes for CD33 and S100A8/9 in cervical cancer patients TRL-positive versus TRL-negative patients. | Nature Communications

Fig. 5: Immunoreactivities of resected lymph nodes for CD33 and S100A8/9 in cervical cancer patients TRL-positive versus TRL-negative patients.

From: Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies

Fig. 5: Immunoreactivities of resected lymph nodes for CD33 and S100A8/9 in cervical cancer patients TRL-positive versus TRL-negative patients.The alternative text for this image may have been generated using AI.

a CD33 expression in cervical cancer patients according to white blood cell counts. Photographs; representative CD33-stained lymph node sections from cervical cancer patients. A graph; proportion of patients with CD33-high. b S100A8 expression in cervical cancer patients according to white blood cell counts. Photographs; representative S100A8-stained lymph node sections from cervical cancer patients. A graph; proportion of patients with S100A8-high. (c) S100A9 expression in cervical cancer patients according to white blood cell counts. Photographs; representative S100A9-stained lymph node sections from cervical cancer patients. A graph; proportion of patients with S100A9-high. Scale bars, 50 μm. Statistical significance was assessed using two-sided Fisher’s exact test (TRL-positive: WBC ≥ 9000/mL, n = 20; TRL-negative: WBC < 9000/mL, n = 20). Source data are provided as a Source Data file.

Back to article page